Please login to the form below

Not currently logged in

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

AZ launches science blog LabTalk

Hopes new blog will build relationships with potential collaborators

AZ LabTalk science blog

AstraZeneca has expanded its blogging efforts with a new science-focused blog that it hopes will grow into an online scientific forum.

The new site aims to be a place that scientists from within AZ and the wider industry can discuss “cutting-edge science and innovation” and – perhaps somewhat hopefully - share their ideas and approaches.

Oliver Stohlmann, vice president of R&D communications, said: “The value of LabTalk is not only to raise the profile of innovative science, but it also gives AstraZeneca the opportunity to hear from our peers.

“Over time we hope to build up a rich library of content that will help tell the R&D story, both from AstraZeneca's and others' perspectives.”

The new initiative builds on AZ's Letters From The Lab articles that started running on its corporate website earlier this year, and adds traditional blogging tools for commenting and sharing to improve engagement.

“What's more,” Stohlmann added, “it will create a platform to showcase the great work of our scientists, making our work more transparent to potential collaborators.”

LabTalk will feature scientists, researchers and academics discussing “novel ideas, research and innovation”.

Introducing the blog, AZ's R&D president Martin Mackay said it would present “a fresh and different way to engage with new and existing peers, partners and others”.

“Simply put, we're going to discuss innovation in an innovative way which, I hope you will agree, is a welcome departure for big pharma,” he wrote.

The blog's regular authors will include VP of oncology science Kevin Webster; head of infection, global medicines development John Rex; and VP of AZ's 'virtual' Neuroscience iMed unit Samantha Budd.

LabTalk joins an expanding pharma blogosphere to sit alongside AZ's existing corporate AZ Health Connections blog and new or forthcoming initiatives from the likes of Lilly, Bayer and Boehringer. On the science front LabTalk joins Pfizer's Think Science Now and Lilly's Clinical Open Innovation.

• For full links to all these pharma blogs and more visit the Digital Handbook

1st October 2012

From: Marketing



Featured jobs

Subscribe to our email news alerts


Add my company
Serviceplan Health & Life

We are your creative global lead agency, your Pan-European hub and your worldwide network....

Latest intelligence

White paper download: Creating experiences to improve patient outcomes
Download our white paper "Creating experiences to improve patient outcomes" to learn the steps to building an effective customer experience strategy....
Organisational Memory
In a knowledge-based industry with high labour mobility, retaining that knowledge within an organisation during a drug’s lifecycle can be tricky. If we undervalue the knowledge, experience and marketing understanding...
Thoughts on the intersection between technology and psychology
Paul Mannu - Master Practitioner, Behavioural Insights at Cello Health Insight gives us his succinct thoughts on the intersection between technology and psychology...